RCEL vs. TMCI, CBLL, SMLR, DCTH, BFLY, RXST, CARL, SNWV, NPCE, and CLPT
Should you be buying Avita Medical stock or one of its competitors? The main competitors of Avita Medical include Treace Medical Concepts (TMCI), CeriBell (CBLL), Semler Scientific (SMLR), Delcath Systems (DCTH), Butterfly Network (BFLY), RxSight (RXST), Carlsmed (CARL), Sanuwave Health (SNWV), NeuroPace (NPCE), and ClearPoint Neuro (CLPT). These companies are all part of the "medical equipment" industry.
Avita Medical vs. Its Competitors
Treace Medical Concepts (NASDAQ:TMCI) and Avita Medical (NASDAQ:RCEL) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, risk, institutional ownership, profitability, analyst recommendations and dividends.
Treace Medical Concepts has a beta of 0.71, suggesting that its share price is 29% less volatile than the S&P 500. Comparatively, Avita Medical has a beta of 1.58, suggesting that its share price is 58% more volatile than the S&P 500.
Treace Medical Concepts has higher revenue and earnings than Avita Medical. Treace Medical Concepts is trading at a lower price-to-earnings ratio than Avita Medical, indicating that it is currently the more affordable of the two stocks.
84.1% of Treace Medical Concepts shares are owned by institutional investors. Comparatively, 27.7% of Avita Medical shares are owned by institutional investors. 27.7% of Treace Medical Concepts shares are owned by insiders. Comparatively, 2.8% of Avita Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
In the previous week, Avita Medical had 1 more articles in the media than Treace Medical Concepts. MarketBeat recorded 9 mentions for Avita Medical and 8 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 0.96 beat Avita Medical's score of 0.46 indicating that Treace Medical Concepts is being referred to more favorably in the media.
Treace Medical Concepts presently has a consensus price target of $9.83, indicating a potential upside of 36.20%. Avita Medical has a consensus price target of $11.60, indicating a potential upside of 154.39%. Given Avita Medical's stronger consensus rating and higher possible upside, analysts plainly believe Avita Medical is more favorable than Treace Medical Concepts.
Treace Medical Concepts has a net margin of -23.01% compared to Avita Medical's net margin of -68.87%. Treace Medical Concepts' return on equity of -46.76% beat Avita Medical's return on equity.
Summary
Treace Medical Concepts beats Avita Medical on 10 of the 16 factors compared between the two stocks.
Get Avita Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for RCEL and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding RCEL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Avita Medical Competitors List
Related Companies and Tools
This page (NASDAQ:RCEL) was last updated on 9/12/2025 by MarketBeat.com Staff
Free RCEL Stock Alerts